CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Planned sale SVP, Chief Financial Officer sold 446 shares at $1.72 ($769)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 726 shares at $1.72 ($1,252)
- 4 Planned sale CEO sold 15,192 shares at $1.72 ($26,196)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 4,109 shares at $1.71 ($7,030)
- 4 Planned sale CEO sold 16,632 shares at $1.71 ($28,452)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,891 shares at $1.71 ($4,946)
- 4 Planned sale CEO sold 1,618 shares at $2.08 ($3,361)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 541 shares at $2.08 ($1,124)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 518 shares at $3.42 ($1,774)
- 4 Planned sale CEO sold 1,555 shares at $3.42 ($5,325)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 11,886 shares at $5.42 ($64,370)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 6,619 shares at $5.21 ($34,456)
- 4 Planned sale CEO sold 12,191 shares at $5.50 ($66,997)
- 4 Planned sale EVP, CHIEF MEDICAL OFFICER sold 511 shares at $5.50 ($2,808)
- 4 Derivatives Options or other derivatives
Page 3 of 18 · 351 filings